ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Gene Expression"

  • Abstract Number: 1827 • 2016 ACR/ARHP Annual Meeting

    Type I IFN Signature Low and High SLE Subjects with Moderate to Severe Disease Activity Have Distinct Gene Expression Signatures of Immunologic Pathways and Cell Types

    Hao Liu1, Brandon Higgs2, William Rees3, Chris Morehouse4, Katie Streicher5, P Brohawn2, G. Illei6 and K Ranade2, 1Translational Medicine, Medimmune, LLC, Gaithers, MD, 2MedImmune, Gaithersburg, MD, 3Translational Medicine, Medimmune, LLC, Gaithersburg, MD, 4Medimmune, LLC, Gaithers, MD, 5Translational Sciences, MedImmune, LLC, Gaithersburg, MD, 6Medimmune, Gaithersburg, MD

    Background/Purpose: Type I interferon (IFN) has been implicated in SLE pathogenesis, and the majority of subjects with SLE have elevated expression of type I IFN-inducible…
  • Abstract Number: 3230 • 2016 ACR/ARHP Annual Meeting

    Genome-Wide Association Study Identifies Novel Sjögren’s Syndrome Risk Loci in the Regions of NAB1, TYK2, and PTTG1-mir146a

    Christopher J. Lessard1, Indra Adrianto1, John Ice1, Astrid Rasmussen2, Kiely Grundahl3, Jennifer A. Kelly4, R. Hal Scofield1, Simon Bowman5, Susan Lester6, Per Eriksson7, Maija-Leena Eloranta8, Johan G. Brun9, Lasse G. Goransson10, Erna Harboe10, Marika Kvarnström11, Michael T. Brennan12, James Chodosh13, Raj Gopalakrishnan14, Andrew J.W. Huang15, Pamela Hughes16, David M. Lewis17, Michael D. Rohrer18, Donald U. Stone19, Nelson L. Rhodus20, Barbara M. Segal21, Lida Radfar22, A. Darise Farris23, Joel M. Guthridge24, Patrick M. Gaffney1, Judith A. James1, John B. Harley25, Lars Rönnblom8, Juan-Manuel Anaya26, Deborah S. Cunninghame-Graham27, Timothy J. Vyse28, Ilias Alevizos29, Xavier Mariette30, Roald Omdal10, Marie Wahren-Herlenius31, Torsten Witte32, Roland Jonsson33, Maureen Rischmueller34, Lindsey A. Criswell35, Courtney G. Montgomery1, Wan-Fai Ng36, Gunnel Nordmark37 and Kathy L. Sivils1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, USA, Oklahoma City, OK, 3Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, 4Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, 6Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia, 7University Hospital, Rheumatology clinic, Linköping, Sweden, 8Uppsala University, Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala, Sweden, 9Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, 10Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 11Karolinska Institutet, Stockholm, Sweden, 12Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC, 13Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 14Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 15Washington University,, St Louis, MO, 16Division of Oral and Maxillofacial Surgery, Department of Developmental and Surgical Science, University of Minnesota School of Dentistry, Minneapolis, MN, 17Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 18Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 19Dean McGee Eye Institute, Oklahoma City, OK, 20Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 21Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN, 22Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 23Arthritis & Immunology Program, Oklahoma Medical Research Foun, Oklahoma City, OK, 24Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 25Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Childrens Hospital, Cincinnati, OH, 26Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogotá, Colombia, 27Department of Medical and Molecular Genetics, King's College London, London, United Kingdom, 28Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, United Kingdom, 29Sjögren's Syndrome Clinic, National Institute of Dental and Craniofacial Research, Bethesda, MD, 30Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France, 31Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 32Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, 33Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 34Rheumatology, University of Adelaide, Adelaide, Australia, 35Division of Rheumatology, UCSF, San Francisco, CA, 36Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 37Rheumatology, Department of Medical Sciences, Uppsala University, Sweden, Uppsala, Sweden

    Background/Purpose: Sjögren’s syndrome (SS) is a complex autoimmune disease with both environmental and genetic factors contributing to pathophysiology. The goal of this genome-wide association study…
  • Abstract Number: 802 • 2016 ACR/ARHP Annual Meeting

    Whole Transcriptome Profiling through RNA Sequencing Reveals Differentially Expressed Sense-Antisense Gene Pairs in Patients with Systemic Sclerosis

    Tobias Messemaker1,2, Loubna Chadli3, Varshna Goelela3, Maaike Boonstra4, Annemarie Dorjee4, Stefan Andersen3, Harald Mikkers2, Tom WJ Huizinga4, Zhenghui Li5, Guoshuai Cai5, Michael Whitfield6, René Toes7, Jamil Aarbiou3, Jeroen De Groot3, Jeska K. de Vries-Bouwstra4 and Fina Kurreeman4, 1Department of Rheumagoloty, Leiden University Medical Center, Leiden, Netherlands, 2Department of Molecular cell Biology, Leiden University Medical Center, Leiden, Netherlands, 3Charles River Nederland B.V., Leiden, Netherlands, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH, 6Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 7Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of skin and multiple organs. Morbidity and mortality are high and pathogenesis is poorly…
  • Abstract Number: 1841 • 2016 ACR/ARHP Annual Meeting

    Dysregulation of the Splicing Machinery Components in Leukocytes from Patients with Systemic Lupus Erythematosus: Influence on Autoimmune and Atherothrombotic Mechanisms

    Chary Lopez-Pedrera1, Sergio Pedraza-Arévalo2, Mercedes del Río-Moreno2, Maria Ángeles Aguirre Zamorano1, Patricia Ruiz-Limon3, Nuria Barbarroja1, Yolanda Jiménez-Gómez1, Ivan Arias de la Rosa3, Eduardo Collantes-Estévez1, Pedro Segui1, Maria Jose Cuadrado4, Justo P Castaño2, Raul M Luque2 and Carlos Perez-Sanchez1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Department of Cell Biology, Physiology and Immunology. University of Cordoba, Hospital Universitario Reina Sofia (HURS), Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), CIBERobn, and ceiA3, Córdoba, Spain, 3Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 4St Thomas Hospital, Lupus Research Unit, London, United Kingdom

    Background/Purpose:  The aim of this study was to evaluate whether alterations in the splicing-machinery could influence the development and activity of the disease and the…
  • Abstract Number: 803 • 2016 ACR/ARHP Annual Meeting

    Multi-Organ RNA-Sequencing of Systemic Sclerosis (SSc) Patients Shows Reproducible Gene Expression Profiles Across Organ Systems

    Bhaven K. Mehta1, Michael E. Johnson1, Kimberly A. Archambault1, Tammara A. Wood2, Antonia Valenzuela3, Amanda Crawford4, David Fiorentino5, Nielsen Fernandez-Becker6, Laren Becker6, Linda Nguyen6, Francesco Boin7, Paul Wolters8, Lorinda Chung9 and Michael Whitfield2, 1Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 3Stanford University School of Medicine, Stanford, CA, 4Dermatology, Stanford University, Redwood City, CA, 5Dermatology, Stanford University, Stanford, CA, 6Gastroenterology & Hepatology, Stanford University School of Medicine, Palo Alto, CA, 7Rheumatology, University California San Francisco, San Francisco, CA, 8Pulmonary Division, Department of Medicine, University of California, San Francisco, San Francisco, CA, 9Rheumatology, Stanford University Medical Center, Palo Alto, CA

    Background/Purpose:  While a hallmark of systemic sclerosis (SSc) is skin fibrosis, internal organ involvement is the primary cause of mortality. Pulmonary Arterial Hypertension (PAH), Interstitial…
  • Abstract Number: 1843 • 2016 ACR/ARHP Annual Meeting

    Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established SLE-Risk Loci in Lupus Patient Monocytes

    Yogita Ghodke-Puranik1, Zhongbo Jin1, Wei Fan2, Mark A. Jensen3, Jessica M. Dorschner1, Danielle Vsetecka1, Shreyasee Amin4, Ashima Makol4, Floranne C. Ernste5, Thomas Osborn4, Kevin Moder4, Vaidehi Chowdhary4 and Timothy B. Niewold6, 1Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 2Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, China, Shanghai, China, 3Department of Immunology and Division of Rheumatology, Mayo Clinic, Rochester, MN, 4Rheumatology, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic, Rochester, MN, 6Rheumatology and Immunology, Mayo Clinic, Rochester, MN

    Background/Purpose:  While most of the confirmed SLE-risk loci are in or near genes with immune system function, a major unanswered question is how these loci…
  • Abstract Number: 816 • 2016 ACR/ARHP Annual Meeting

    Clinical Response to Treatment with Belimumab and Mycophenolate Mofetil Is Associated with Decrease in B Cell, TGF-β and PDGF Signaling in Systemic Sclerosis

    Viktor Martyanov1, Jessica K. Gordon2, Tammara A. Wood1, Robert F. Spiera2 and Michael L. Whitfield1, 1Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: While B cell signaling is thought to be important in the pathogenesis of systemic sclerosis (SSc), the experience with B cell targeting therapies in…
  • Abstract Number: 1902 • 2016 ACR/ARHP Annual Meeting

    Detecting the Pulmonary Vascular Involvement and the Changes in Gene Activation Profiles at Early Stage of Systemic Sclerosis in Patients with Raynaud Phenomenon

    Yoshinobu Koyama1, Soichiro Fuke2, Yoshiharu Sato3 and Toshie Higuchi4, 1Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan, 2Department of Cardiology, Japan Red Cross Okayama Hospital, Okayama, Japan, 3DNA Chip Research Inc, Yokohama, Japan, 4Center for Autoimmune Diseases, Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan

    Background/Purpose: Raynaud phenomenon (RP) is known to precede other disease manifestations of systemic sclerosis (SSc), and classically viewed as reversible vasospasm due to functional changes…
  • Abstract Number: 1036 • 2016 ACR/ARHP Annual Meeting

    Dominant B-Cell Receptor Clones in Peripheral Blood Predict Onset of Arthritis in Individuals at Risk for Rheumatoid Arthritis

    Paul-Peter Tak1,2,3, Marieke E. Doorenspleet4, Maria de Hair5, Paul L. Klarenbeek6, Marian van Beers-Tas7, Antoine H.C. van Kampen8, Dirkjan van Schaardenburg9,10, Danielle M. Gerlag11,12, Frank Baas13 and Niek de Vries14, 1Clinical Immunology & Rheumatology F4.105, Amsterdam Rheumatology and Immunology Center, Department of Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Currently: GlaxoSmithKline, Stevenage, UK, Stevenage, United Kingdom, 3currently: Ghent University, Ghent, Belgium & Cambridge University, Cambridge, United Kingdom, 4Dept. of Clinical Immunology & Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 5Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 6Dept. of Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 7Rheumatology, Amsterdam Rheumatology & Immunology Center, Reade, Amsterdam, Netherlands, 8Dept Clin Epidemiology, Biostatistics & Bioinformatics, Academic Medical Center/Univ. of Amsterdam, Amsterdam, Netherlands, 9Clinical Immunology & Rheumatology F4.105, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, 10Rheumatology, Amsterdam Rheumatology and immunology Center, location Reade, Amsterdam, Netherlands, Amsterdam, Netherlands, 11Clinical Immunology & Rheumatology, ARC | Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 12Current address: GSK,Clinical Unit Cambridge,R&D Projects Clinical Platforms & Sciences, Cambridge, United Kingdom, 13Department of Genome Analysis, Academic Medical Center/Univ. of Amsterdam, Amsterdam, Netherlands, 14Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: The onset of seropositive rheumatoid arthritis (RA) is preceded by the presence of specific autoantibodies in the absence of synovial inflammation. Only a subset…
  • Abstract Number: 2059 • 2016 ACR/ARHP Annual Meeting

    Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Factor in T Cell Homeostasis and Its Selective Loss in T Cells Causes Autoimmunity and Lupus-like Nephritis

    Vaishali R. Moulton1, Hao Li2, Michael W. Mosho2, Andrew R. Gillooly2, Meghan L. Keane3 and George C. Tsokos4, 1Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Medicine/ Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Background/Purpose: T cells from patients with systemic lupus erythematosus (SLE) express reduced amounts of the critical CD3 zeta signaling chain, and produce low levels of…
  • Abstract Number: 1210 • 2016 ACR/ARHP Annual Meeting

    A Genome-Wide Association Study of Psoriatic Arthritis in Italian Population

    Mariagrazia Catanoso1, Pierluigi Macchioni1, Salvatore D'Angelo2, Antonio Marchesoni3, Roberta Ramonda4, Alberto Cauli5, Fabio Massimo Perrotta6, Roberto Bortolotti7, Guseppe Provenzano8, Giovanni Pistone9, Katya Boito10, Cristina Giuliani11, Paolo Garagnani11, Davide Gentilini12, Mariana Lofrano13, Laura Rotunno14, Mariagrazia Lorenzin15, Ignazio Olivieri13, Alessandro Mathieu16, Guido Valesini17, Giuseppe Paolazzi7, Roberto Baricchi18, Anna Maria Di Blasio12, Luigi Boiardi19, Claudio Franceschi20 and Carlo Salvarani1, 1Rheumatology Unit, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, matera, Italy, 3Rheumatology Unit, Orthopedic Institute G. Pini, Milano, Italy, 4Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy, 5University of Cagliari, Cagliari, Italy, 6Rheumatology Unit, Sapienza University, Department of Internal Medicine and Medical Specialties, Roma, Italy, 7Rheumatology Unit, Santa Chiara Hospital, Trento, Italy, 8Reumatology Unit, Villa Sofia-CTO Hospital, Palermo, Italy, 9Rheumatology Unit, ARNAS Civico, Di Cristina e Benfratelli Hospital, Palermo, Italy, 10Transfusion Medicine Unit,, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy, 11Laboratory of Molecular Anthropology, Centre for Genome Biology University, Bologna, Italy, 12Laboratory of Molecular Biology, Istituto Auxologico Italiano, IRCCS, Milano, Italy, 13Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Matera, Italy, 14Orthopedic Institute G.Pini, Rheumatology Unit, Milano, Italy, 15Department of Medicine, University of Padova - Rheumatology Unit, Padova, Italy, 16Department of Medical Sciences, Rheumatology Unit - University of Cagliari, Cagliari, Italy, 17Internal Medicine and Medical Specialties Department, Policlinico Umberto I, La Sapienza University of Rome, Roma, Italy, 18Transfusion Medicine Unit, IRCCS S. Maria Nuova Hospital, Reggio Emilia, Italy, 19Rheumatology Unit, Arcispedale S.Maria Nuova, IRCCS, Reggio Emilia, Italy, 20Laboratory of Molecular Anthropology & Centre for Genome Biology University of Bologna, Bologna, Italy

    rexm-rs12191877 (p=4.87 x10-10, OR 1.731, 95%CI =1.46-2.06), exm-rs4947248 (p=1.98 x10-9 , OR 1.56, 95%CI = 1.35-1.80). Moreover, in PsA patients we identified signals of association…
  • Abstract Number: 2064 • 2016 ACR/ARHP Annual Meeting

    Blood and Kidney Molecular Profiles Distinguish Subjects with Lupus Nephritis from Other Kidney Disorders

    Matteo Cesaroni1, Jarrat Jordan1, Marc Chevrier2, Alan Perlman3, James M. Chevalier4, Thomas Parker3, Daniel Levine3, Surya V. Seshan5, Anna Gong6, Takahiro Sato1 and Jacqueline Benson1, 1Estrela Lupus Venture, Janssen Research and Development, LLC., Spring House, PA, 2Janssen Research and Development, LLC, Collegeville, PA, 3The Rogosin Institute,New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, NY, 4Nephrology, The Rogosin Institute New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, 5Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, NY, 6The Rogosin Institute,New York Presbyterian Hospital-Weill Medical College of Cornell University, new york, NY

    Background/Purpose: Kidney biopsy remains the gold standard for diagnosis and staging of Lupus Nephritis (LN). Although kidney biopsies are commonly performed in the clinical setting,…
  • Abstract Number: 1211 • 2016 ACR/ARHP Annual Meeting

    Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

    Matthew T. Weirauch1, Daniel Miller1, Leah C. Kottyan2, Ignacio Ibarra3, Sayeed Syed4, Xiaoting Chen1, Erin Zoller1, Arthur Lynch1, Connor Schroeder1, Josh Lee1, Albert Magnussen1, Ally Yang5, Timothy R. Hughes5, Joo-Seop Park1, Charles Vinson4 and John B. Harley6,7, 1Cincinnati Childrens Hospital, Cincinnati, OH, 2Center for Autoimmune Genomics and Etiology, Cincinnati Childrens Hospital, Cincinnati, OH, 3EMBL, Heidelberg, Germany, 4NCI, Bethesda, MD, 5University of Toronto, Toronto, ON, Canada, 6US Department of Veterans Affairs Medical Center, Cincinnati, OH, 7Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Childrens Hospital, Cincinnati, OH

    Methods: We tested the hypothesis that some autoimmune variants might act by altering the binding of the EBV-encoded transcription factor ZTA, consequently resulting in downstream…
  • Abstract Number: 2138 • 2016 ACR/ARHP Annual Meeting

    Transcriptional Analysis of Synovial Tissue Reveals Sustained Inflammatory Chemokine Expression Despite Minimal Histopathologic Change in the Destabilization of Medial Meniscus Model of Murine Knee Osteoarthritis

    Nisha Sambamurthy1,2, Vu Nguyen1,2, Jason G. Lieberthal3, George R. Dodge4,5 and Carla R. Scanzello1,2,5, 1Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2Translational Musculoskeletal Research Center, CMC Veterans Affairs Medical Center, Philadelphia, PA, 3Internal Medicine, Mount Auburn Hospital, Cambridge, MA, 4Research, CMC Veterans Affairs Medical Center, Philadelphia, PA, 5Department of Orthopedic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

    Background/Purpose: The destabilization of medial meniscus (DMM) model of instability-induced OA replicates disease-related tissue pathology (including cartilage erosion, osteophytosis) and pain-related joint dysfunction, making it…
  • Abstract Number: 1216 • 2016 ACR/ARHP Annual Meeting

    Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness

    John A. Ice1, Indra Adrianto1, Astrid Rasmussen1, Kiely Grundahl2, Michelle L. Joachims3, Graham B. Wiley1, Jennifer A. Kelly1, Glen D. Houston4, David M. Lewis4, Lida Radfar5, Donald U. Stone6,7, Barbara M. Segal8, Nelson L. Rhodus9, Joel M. Guthridge3, James Chodosh10,11, Raj Gopalakrishnan12, Andrew J.W. Huang13, Pamela J Hughes14, Michael D. Rohrer15, Judith A. James1,16,17, Courtney G. Montgomery1, R. Hal Scofield1,17,18, Patrick Gaffney1, Kathy L. Sivils3 and Christopher J. Lessard1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 5Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8Rheumatology, Hennepin County Medical Center, Minneapolis, MN, 9Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 10Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 11Harvard Medical School, Boston, MA, 12Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota School of Dentistry, Minneapolis, MN, 13Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, MO, 14Department of Oral and Maxillofacial Surgery, Oregon Health & Science University School of Dentistry, Portland, OR, 15Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, 16Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 18US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disorder in which exocrine dysfunction can lead to chronic, debilitating dryness. Expression studies in SS have identified…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 31
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology